Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreoni

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemiaD Armenia, L Fabeni, C Alteri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitroR Salpini, M Surdo, M F Cortese, et al.
Infection|May 30, 2009
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapyA Antinori, A Ammassari, C Torti, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14L Fabeni, C Alteri, D Di Carlo, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Infection|October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupV Svicher, C Alteri, M Montano, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemiaD Armenia, L Fabeni, C Alteri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitroR Salpini, M Surdo, M F Cortese, et al.
Infection|May 30, 2009
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapyA Antinori, A Ammassari, C Torti, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14L Fabeni, C Alteri, D Di Carlo, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Infection|October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupV Svicher, C Alteri, M Montano, et al.
Pageof 16